Gregory R. Johnson

Gregory R. Johnson is a computational biologist and machine learning scientist based in San Francisco. He co-founded NewLimit in 2022, where he served as Head of Machine Learning to develop epigenetic reprogramming therapies for age-related diseases, and is currently a Member of Technical Staff at EvolutionaryScale. He is best known for inventing label-free prediction of three-dimensional fluorescence images from transmitted-light microscopy during his tenure at the Allen Institute for Cell Science, and for developing generative models of cellular organization. He holds a PhD in computational biology from Carnegie Mellon University.